2024

Heads (Health Data Specialists) is a full-service Global Contract Research Organization (CRO) dedicated to the conduct of clinical studies, with expertise in oncology studies. Veeda Clinical Research, together with its subsidiary Bioneeds, offers a comprehensive portfolio of clinical, preclinical and bio-analytical services to support innovator, biosimilar and generic drug development programs of global clients. Heads

Aastha Maheshwari 30 January, 2024 India-focused mid-market private equity firm Sabre Partners has raised around $73 million for its fourth fund to back companies in fintech, healthcare and health tech sectors, a top executive told DealStreetAsia. “We have received commitments of $73 million for our recent fund. The fund will look for opportunities where it

This article was originally posted on: https://www.crisilratings.com/mnt/winshare/Ratings/RatingList/RatingDocs/AviomIndiaHousingFinancePrivateLimited_May%2018,%202023_RR_318688.html Download the Rating Rationale PDF from here Rating Rationale May 18, 2023 | Mumbai Aviom India Housing Finance Private Limited Rating upgraded to ‘CRISIL BBB+/Stable’; Rated amount enhanced for Bank Debt Rating Action Total Bank Loan Facilities Rated Rs.125 Crore (Enhanced from Rs.25 Crore) Long Term Rating CRISIL

This article was originally posted on: https://www.thehindubusinessline.com/news/national/mylab-and-ekincare-to-promote-serum-institutes-nasal-flu-vaccine-among-corporates/article67579438.ece Coverage in Economic Times can be read on: https://health.economictimes.indiatimes.com/news/diagnostics/mylab-collaborates-with-ekincare-to-promote-nasovac-s4-influenza-nasal-vaccine/105562482 Ekincare is a corporate health benefits platform and its collaboration with Mylab will enable businesses to incorporate NASOVAC-S4 into their employee wellness programs Diagnostics solutions provider Mylab is partnering with Ekincare to promote the nasal influenza vaccine NASOVAC-S4, developed